USNA
USANA HEALTH SCIENCES INC
Key Financials
Revenue
$925.3M
↑ 8.3%
Gross Profit
$724.4M
↑ 4.5%
Net Income
$10.8M
↓ 74.4%
Operating Income
$37.4M
↓ 43.6%
Total Assets
$742.9M
↓ 0.7%
Total Liabilities
$156.6M
↓ 3.2%
EPS (Diluted)
$0.58
↓ 73.5%
Shareholders' Equity
$533.1M
↑ 0.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | USNA |
| Company Name | USANA HEALTH SCIENCES INC |
| CIK | 896264 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Accelerated filer |
| Exchange | NYSE |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 0103 |
| State of Incorporation | UT |
| Phone | 8019547100 |